首页> Ophthalmology. Retina> A Meta-Analysis of Intravitreal Ranibizumab versus Laser Photocoagulation for the Treatment of Retinopathy of Prematurity.

A Meta-Analysis of Intravitreal Ranibizumab versus Laser Photocoagulation for the Treatment of Retinopathy of Prematurity.

导出 LinkOut

翻译打印收藏纠错

第一作者： Abed A,Baiad

第一单位： Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, Canada.

作者： Abed A,Baiad ^[1] ; Catherine,Sun ^[2] ; Grace S,Yin ^[3] ; Marko M,Popovic ^[4] ; Rajeev H,Muni ^[5] ; Kamiar,Mireskandari ^[6] ; Peter J,Kertes ^[7]

作者单位： Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, Canada. ^[1] Faculty of Medicine, McMaster University, Hamilton, Canada. ^[2] Faculty of Medicine, Queen's University, Kingston, Canada. ^[3] Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada. ^[4] Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada; Department of Ophthalmology, St. Michael's Hospital/Unity Health Toronto, Toronto, Canada. ^[5] Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada; Department of Ophthalmology, Hospital for Sick Children, Toronto, Canada. ^[6] Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada; John and Liz Tory Eye Centre, Sunnybrook Health Sciences Centre, Toronto, Canada. Electronic address: peter.kertes@sunnybrook.ca. ^[7]

关键词 Laser photocoagulation Ranibizumab Retinopathy of prematurity Vascular endothelial growth factors